Evidence map›Paper›PMID 27587406›Full record

ArticleCirculation research2016

Bone Marrow Takes Center Stage in Cardiovascular Disease.

Filip K Swirski, Matthias Nahrendorf

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Bone marrow vasculature advancedFrontiers in cardiovascular medicine · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Vascular toxic effects of cancer therapies.Nature reviews. Cardiology · 2020
    Review
  6. Article
  7. Evidence for a Causal Role of the SH2B3-βHypertension (Dallas, Tex. : 1979) · 2019
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Filip K SwirskiFrom the Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston. fswirski@mgh.harvard.edu mnahrendorf@mgh.harvard.edu.
Matthias NahrendorfFrom the Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston.

Funding

Monocyte Heterogeneity in Experimental and Human AtherosclerosisR01HL095612 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SWIRSKI, FILIP K · 2009 to 2016
$3.4M
Lifestyle effects on hematopoiesis and atherosclerosisR01HL128264 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS, SWIRSKI, FILIP K · 2015 to 2018
$3.3M
Dynamic interactions between ischemic stroke, immunity and the bone marrowR01NS084863 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSKOWITZ, MICHAEL A., NAHRENDORF, MATTHIAS · 2014 to 2018
$3.2M
PET/MRI of cardiac repairR01HL096576 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS · 2009 to 2017
$2.8M
Imaging of Cardiac Transplant RejectionR01HL095629 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS · 2009 to 2013
$2.2M
NHLBI NIH HHS R01 HL095612NHLBI NIH HHS R01 HL095629NHLBI NIH HHS R01 HL096576NHLBI NIH HHS R01 HL128264NINDS NIH HHS R01 NS084863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone MarrowMyelopoiesisBone Marrow CellsCardiovascular DiseasesHumansatherosclerosiscell proliferationdiabetes mellitusEditorialsmyelopoiesisthrombosis

Identifiers

PMID27587406
PMCPMC5012290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.